To include your compound in the COVID-19 Resource Center, submit it here.

Atara prices $127.8M follow-on

Atara Biotherapeutics Inc. (NASDAQ:ATRA) raised $127.8 million through the sale of 7 million shares

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE